MedCity News

Why Epic Is Launching a Prescription Price Comparison Tool

City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver

City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The company’s technology for designing RNAi drugs and delivering them to tissues throughout the body has already led to partnerships with Bausch + Lomb in eye diseases and Biogen in central nervous system disorders.

By Frank Vinluan

MedCity Influencers

A dynamic 3D illustration featuring a long, curved arrow with focus circles along its path, each marked with a check signifying approval and progress. On both sides of the arrow are 3D mechanical gears, also containing check marks at their centers. This design symbolizes process flow, efficiency, and successful task completion. The interconnection of the arrow and gears visually conveys the seamless interaction and synchronization of components in a workflow. Ideal for concepts such as project management, quality assurance, and operational excellence, the design's modern aesthetic and bold 3D elements make it visually compelling and informative.

The Impending End of Cross-Subsidization

There is no single solution to the cross-subsidization problem. But here are some strategic actions that can make a health system’s economics more sustainable.

By Brian Fisher and Jeff Goldsmith

MedCity Influencers

How AI Is Connecting MedTech’s Data Without Compromising Compliance

The connected, agent-ready enterprise is the model that wins, where compliance and intelligence operate together.

By Chuck Serrin

Latest Video

Latest News

Health Tech

Yellow house icon connected with Ethernet cables on blue background, Smart home networking, internet, and IoT connectivity.

Rosarium Health Forms Home Modification Partnership with Anthem Medi-Cal

Rosarium Health partnered with Anthem Medi-Cal to provide home safety modifications for eligible members.

By Marissa Plescia

BioPharma, Artificial Intelligence

Cancer cell view - 3d rendered image, enhanced scanning electron micrograph (SEM) of cancer cell. Visual of overall shape of the cell's surface at a very high magnification. Medical research concept.

AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D

Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline of internally discovered and wholly owned cancer drugs. Iambic also has R&D alliances with companies such as Bayer and AbbVie.

By Frank Vinluan

MedCity Influencers

Why the Future of Healthcare Depends on Reinventing Primary Care Access

What is needed is a fundamentally different operating model for primary care, one designed around continuous engagement rather than episodic encounters.

By Jean-Claude Saghbini

Health Tech

HealthTap Introduces Virtual Primary Care Program for DME Suppliers

HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy.

By Marissa Plescia

BioPharma, Pharma

Ultragenyx Rare Disease Voucher Sales Secure $413M for More Potential Pipeline Building

Ultragenyx Pharmaceutical sold two priority review vouchers, each from an FDA approval of a gene therapy. Both therapies came from business deals and proceeds from the voucher sales put Ultragenyx in a better financial position to pursue yet another deal for a rare disease asset.

By Frank Vinluan

Artificial Intelligence Physicians,

Jet trail creating dollar sign in blue sky with clouds startup capital

Healthleap Raises $38M to Expand AI Screening for Overlooked Conditions in Hospitalized Patients

Healthleap, a clinical AI platform that works within the EHR to screen hospitalized patients for conditions that might otherwise go undiagnosed, is supporting hospitals in finding at-risk patients sooner.

By Jenna Congdon

MedCity Influencers

Why Pharma Companies Should Look To Social Media For Better Patient Insight

Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.

By Rohit Marwah

MedCity Influencers

A digitally generated image featuring an old-style computer monitor displaying the letters “AI” with neon business crowd. The scene blends retro computing with modern business aesthetics, symbolizing the journey of artificial intelligence from its early beginnings to its growing role in today’s corporate world. Ideal for illustrating themes of digital evolution, business transformation, AI adoption, and technology-driven innovation.

Why Agentic AI Works in Hospitals When You Strip It Down

Many hospitals are now trying to use AI to automate processes and free up staff time, running simultaneous pilots to perform as many tasks as possible. This quickly leads to pilot sprawl — a state where organizations can no longer even say which agents are still in active use.

By Mykhailo Hentosh

Devices & Diagnostics

Happy Health’s Cuffless BP Device Wins FDA Clearance

Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or external calibration.

By Jenna Congdon

BioPharma, Pharma

Roche Puts Up $100M to Pursue Promising But Competitive New Target in Obesity

Roche gains global rights to a Rona Therapeutics RNA interference drug designed to target ALK7, a genetically validated target for obesity and other metabolic indications. The growing field of companies pursuing ALK7 includes GSK and Arrowhead Pharmaceuticals.

By Frank Vinluan

Opinion

Medicare Policy Shouldn’t Be Made in the Shadows

Medicare policy should be transparent and include appropriate notice and stakeholder input. And when a contractor gets it wrong, there should be a clear and rapid way to stop the harm to patients, their relationship with their doctor and the doctor’s practice.

By Dr. Chris Phillips

MedCity Influencers

What Corporate Venture Funds Get Wrong about Strategic Value

Corporate venture funds often chase financial returns while ignoring strategic value. Here’s what it takes to turn healthcare portfolio investments into lasting business impact.

By David M. Rubin

BioPharma, Pharma

Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug

Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures.

By Frank Vinluan

Health Tech

Outro Raises $7M To Support Safe Deprescribing

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures.

By Marissa Plescia

MedCity Influencers

Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem

Investing in pediatric care is not simply a moral imperative. It is one of the most practical long-term investments the healthcare system can make.

By Scott Xiao